Cargando…
Cellular Therapy for the Treatment of Paediatric Respiratory Disease
Respiratory disease is the leading cause of death in children under the age of 5 years old. Currently available treatments for paediatric respiratory diseases including bronchopulmonary dysplasia, asthma, cystic fibrosis and interstitial lung disease may ameliorate symptoms but do not offer a cure....
Autores principales: | Brennan, Laura C., O’Sullivan, Andrew, MacLoughlin, Ronan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396271/ https://www.ncbi.nlm.nih.gov/pubmed/34445609 http://dx.doi.org/10.3390/ijms22168906 |
Ejemplares similares
-
Cellular Immunotherapy and the Lung
por: Daly, Sorcha, et al.
Publicado: (2021) -
Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
por: Woods, Niamh, et al.
Publicado: (2020) -
State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery
por: Brave, Hosanna, et al.
Publicado: (2020) -
In vitro evaluation of disposable transport ventilators with combination aerosol therapy
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021) -
Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
por: Fernández Fernández, Elena, et al.
Publicado: (2021)